The present invention relates to a substantially pure population of viable pancreatic progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.

 
Web www.patentalert.com

< Cells producing antibody compositions with increased antibody dependent cytotoxic activity

< Complementing cell lines

> Transgenic plant transformed with a translationally controlled tumor protein (TCTP) gene

> Cytokine protein family
~ 00208